Intermittent fasting has become one of the most discussed topics in metabolic health. That’s partly because it works — and partly because “intermittent fasting” covers several different approaches that work in different ways, to different degrees, for different people.
Let’s break down the three most studied approaches and what the blood sugar evidence shows for each.
16:8 (time-restricted eating)
The 16:8 approach means eating within an 8-hour window and fasting for the remaining 16 hours. Most people skip breakfast and eat from roughly noon to 8 PM, though the window can be placed anywhere.
This is by far the most studied form of intermittent fasting for metabolic health. The consistent finding across multiple randomized trials is that 16:8 improves fasting insulin levels and reduces post-meal glucose spikes, even when total calorie intake stays the same.
A 2020 study in Cell Metabolism found that participants who ate within a 10-hour window (not even 8 hours) for 12 weeks saw significant improvements in fasting glucose, A1C, blood pressure, and cholesterol — without being instructed to reduce calories. Some of that benefit may come simply from eliminating late-night eating, which drives blood sugar in a less metabolically efficient window.
An important nuance: when to place the eating window may matter. Emerging research suggests that eating earlier in the day — say, 8 AM to 4 PM rather than noon to 8 PM — produces better metabolic outcomes because insulin sensitivity is higher in the morning. Early time-restricted eating isn’t practical for most people, but it’s worth knowing.
5:2 (periodic fasting)
The 5:2 approach means eating normally five days a week and restricting calories dramatically (usually 500–600 calories) on two non-consecutive days.
The blood sugar evidence for 5:2 is decent but slightly less consistent than for 16:8. A 2020 review in Nutrients found that 5:2 produced similar improvements in A1C and fasting glucose as continuous calorie restriction over 12 to 24 weeks — meaning it’s roughly as effective as just eating less overall, but some people find it easier to sustain because most days are unrestricted.
The challenge with 5:2 for blood sugar management is that the low-calorie days can cause energy swings and, in people on blood sugar medications, hypoglycemia risk. It’s not a beginner-friendly approach if you’re on insulin or sulfonylureas.
OMAD (one meal a day)
OMAD is an extreme version of time-restricted eating: all calories consumed in one meal, usually within a one-to-two-hour window.
The honest answer is that OMAD is understudied in humans. Most of the research on it is observational or short-term. What limited evidence exists suggests it does produce weight loss and improvements in fasting glucose — but it also tends to cause muscle loss if protein isn’t adequate, and many people find it socially unsustainable over time.
For blood sugar management specifically, OMAD can cause large post-meal glucose spikes because all carbohydrates are consumed at once rather than spread across the day.
Which fasting window is worth trying
For most people focused on blood sugar, the evidence most consistently supports 16:8 — specifically, eating in a consistent daily window and avoiding food in the two to three hours before bed. It’s the least disruptive to daily life and has the most randomized trial support.
Whatever approach you choose, the most important factor isn’t which protocol you pick — it’s consistency. Intermittent fasting approaches tend to show benefits after six to eight weeks of consistent practice. Dabbling doesn’t produce the same results.
This content is for educational purposes only and is not medical advice. Consult your healthcare provider before making changes to your diet, supplements, or medications.
